Radiotheranostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global radiotheranostics market is expected to grow at a CAGR of around 13.2% during 2025-2034. This report on global radiotheranostics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global radiotheranostics market by segmenting the market based on radioisotopes, approach, application and region. Also, detailed profiles of companies operating in the radiotheranostics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Growing Prevalence of Cancer • Technological Advancements
Market Challenges
• High Costs
Historical & Forecast Period
Base Year: 2024 Historical Period: 2020-2024 Forecast Period: 2025-2034
Market by Radioisotope
• Iodine-131 • Iodine-123 • Gallium-68 • Lutetium-177 • 18F with Y-90 • Other Radioisotopes
Market by Approach
• Targeted Therapeutic • Targeted Diagnostic
Market by Application
• Oncology Thyroid Cancer Neuroendocrine Tumor Hepatocellular Carcinoma Prostate Cancer Others • Non-oncology Neurological Disorders Arthritis Others
Market by Region
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran United Arab Emirates Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Radiotheranostics Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Radiotheranostics Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Radiotheranostics Market by Radioisotope
5.1. Introduction
5.2. Iodine-131
5.3. Iodine-123
5.4. Gallium-68
5.5. Lutetium-177
5.6. 18F with Y-90
5.7. Other Radioisotopes
6. Global Radiotheranostics Market by Approach
6.1. Introduction
6.2. Targeted Therapeutic
6.3. Targeted Diagnostic
7. Global Radiotheranostics Market by Application
7.1. Introduction
7.2. Oncology
7.2.1. Thyroid Cancer
7.2.2. Neuroendocrine Tumor
7.2.3. Hepatocellular Carcinoma
7.2.4. Prostate Cancer
7.2.5. Others
7.3. Non-oncology
7.3.1. Neurological Disorders
7.3.2. Arthritis
7.3.3. Others
8. Global Radiotheranostics Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Bayer AG
12.2.2. IsoTherapeutics Group, LLC
12.2.3. ITM Radiopharma
12.2.4. Life Molecular Imaging.
12.2.5. Nordic Nanovector ASA.
12.2.6. Novartis AG
12.2.7. Progenics Pharmaceuticals, Inc. (Lantheus)
12.2.8. Q BioMed Inc.
12.2.9. RadioMedix
12.2.10. Telix Pharmaceuticals Limited.
List of Figures
Figure 1: Global Radiotheranostics Market (in US$ Million), 2020-2024
Figure 2: Global Radiotheranostics Market by Radioisotope, 2024
Figure 3: Global Radiotheranostics Market by Approach, 2024
Figure 4: Global Radiotheranostics Market by Application, 2024
Figure 5: Global Radiotheranostics Market by Region, 2024
Figure 6: Global Radiotheranostics Market (in US$ Million), 2025-2034
Figure 7: Global Radiotheranostics Market by Radioisotope (in %), 2024 & 2034
Figure 8: Global Iodine-131 Radiotheranostics Market (in US$ Million), 2020-2024
Figure 9: Global Iodine-131 Radiotheranostics Market (in US$ Million), 2025-2034
Figure 10: Global Iodine-123 Radiotheranostics Market (in US$ Million), 2020-2024
Figure 11: Global Iodine-123 Radiotheranostics Market (in US$ Million), 2025-2034
Figure 12: Global Gallium-68 Radiotheranostics Market (in US$ Million), 2020-2024
Figure 13: Global Gallium-68 Radiotheranostics Market (in US$ Million), 2025-2034
Figure 14: Global Lutetium-177 Radiotheranostics Market (in US$ Million), 2020-2024
Figure 15: Global Lutetium-177 Radiotheranostics Market (in US$ Million), 2025-2034
Figure 16: Global 18F with Y-90 Radiotheranostics Market (in US$ Million), 2020-2024
Figure 17: Global 18F with Y-90 Radiotheranostics Market (in US$ Million), 2025-2034
Figure 18: Global Other Radioisotopes Radiotheranostics Market (in US$ Million), 2020-2024
Figure 19: Global Other Radioisotopes Radiotheranostics Market (in US$ Million), 2025-2034
Figure 20: Global Radiotheranostics Market by Approach (in %), 2024 & 2034
Figure 21: Global Targeted Therapeutic Radiotheranostics Market (in US$ Million), 2020-2024
Figure 22: Global Targeted Therapeutic Radiotheranostics Market (in US$ Million), 2025-2034
Figure 23: Global Targeted Diagnostic Radiotheranostics Market (in US$ Million), 2020-2024
Figure 24: Global Targeted Diagnostic Radiotheranostics Market (in US$ Million), 2025-2034
Figure 25: Global Radiotheranostics Market by Application (in %), 2024 & 2034
Figure 26: Global Oncology Radiotheranostics Market (in US$ Million), 2020-2024
Figure 27: Global Oncology Radiotheranostics Market (in US$ Million), 2020-2034
Figure 28: Thyroid Cancer Oncology Radiotheranostics Market (in US$ Million), 2025-2034